Keystone Heart is focused on protecting the brain from emboli to reduce the risk of brain infarcts during TAVR, atrial fibrillation ablation and other structural heart procedures.

Latest News

Share this

Author: Keystone Heart

Keystone Heart Applauds FDA Advisory Panel

Panel feedback echoes recently published NeuroARC research guidelines CAESAREA, Israel, and TAMPA, Florida — February 27, 2017— Keystone Heart Ltd., an emerging medical device company focused on developing cerebral embolic protection devices for patients undergoing cardiac procedures, applauds the members of the FDA’s Circulatory System Devices...


Interventional Cardiology 2017

March 5-10, 2017   Staying up to date with the latest in neurological protection isn’t just a requirement, it’s a passion of ours. And what better way to study such advancements in the field than attending the Promedica’s 32nd Annual International Symposium at Interventional Cardiology 2017. This...

TVT 2017

Friday, June 16 Chicago Ballroom VIII TVT Friday Morning Breakfast Symposium Program check-in and breakfast begins at 6:30 AM Program will run from 7:00 AM – 8:00 AM Agenda: M Leon; The need for CEP A Lansky: NeuroARC; new stroke guidelines for diagnosis and reporting R Sharma; Meaningful end-points of CEP cl trials...